57. Idiopathic dilated cardiomyopathy Disease details / Clinical trials / Drug dev / DR info


Clinical trials : 11 Drugs : 17 - (DrugBank : 10) / Drug target genes : 9 - Drug target pathways : 35

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
Allopurinol
   University of Pennsylvania
      2003   Phase 1/Phase 2   NCT00281255   United States
Benazepril
   Xijing Hospital
      2005   Phase 4   NCT01917149   China
Bone marrow mononuclear cells
   Barts & The London NHS Trust
      2010   Phase 2   NCT01302171   United Kingdom
Carvedilol
   University of Colorado, Denver
      2000   Phase 4   NCT01798992   United States
Coenzyme Q10
   University of Tehran
      2006   Phase 4   NCT02115581   Iran, Islamic Republic of
Dobutamine
   University of Pennsylvania
      2003   Phase 1/Phase 2   NCT00281255   United States
Granulocyte colony stimulating factor
   Barts & The London NHS Trust
      2010   Phase 2   NCT01302171   United Kingdom
Honey
   mamdouh abdulmaksoud abdulrhman
      2015   Phase 2/Phase 3   NCT02987322   -
Htea
   Harbin Medical University
      2013   -   NCT02292043   China
Infusion OF autologous mononuclear bone marrow cells
   Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
      2014   Phase 2   NCT02033278   Spain
Lenograstim
   Barts & the London NHS Trust
      2010   -   EUCTR2009-013112-12-GB   United Kingdom
Metoprolol
   Xijing Hospital
      2005   Phase 4   NCT01917149   China
Metoprolol succinate + doxazosin
   University of Colorado, Denver
      2000   Phase 4   NCT01798992   United States
Mono nuclear cell (MNC) transplantation
   Nasser Aghdami MD., PhD
      2013   Phase 1/Phase 2   NCT02256501   Iran, Islamic Republic of
Umbilical cord mesenchymal stem cells
   Qingdao University
      2010   Phase 1/Phase 2   NCT01219452   China
Valsartan
   Xijing Hospital
      2005   Phase 4   NCT01917149   China
Water
   Barts & the London NHS Trust
      2010   -   EUCTR2009-013112-12-GB   United Kingdom